2008
DOI: 10.1182/asheducation-2008.1.33
|View full text |Cite
|
Sign up to set email alerts
|

How Is Hodgkin Lymphoma in Pregnancy Best Treated?

Abstract: A 26-year-old woman who is 22 weeks into her first pregnancy presents with a new diagnosis of Hodgkin lymphoma (HL). In preparing for her treatment you wonder about the safety and efficacy of chemotherapy during pregnancy.A comprehensive literature review was conducted to evaluate the safety and effectiveness of chemotherapy for pregnant patients with HL. Medline

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0
3

Year Published

2009
2009
2020
2020

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(22 citation statements)
references
References 19 publications
0
19
0
3
Order By: Relevance
“…Also infants born to mothers with HB had a higher incidence of prematurety and intrauterine retardation of growth and development. There are no data on the metastasis of HD in the placenta or fetus [8].…”
Section: Discussionmentioning
confidence: 99%
“…Also infants born to mothers with HB had a higher incidence of prematurety and intrauterine retardation of growth and development. There are no data on the metastasis of HD in the placenta or fetus [8].…”
Section: Discussionmentioning
confidence: 99%
“…However, favorable pregnancy outcomes have been reported with their use in the second and third trimesters in the patients with malignancies [27]. Experience with thiopurines in pregnancy is primarily in patients with inflammatory bowel disease but has not been reported in pregnant patients with ITP [28].…”
Section: Managementmentioning
confidence: 97%
“…Allerdings ist eine intensive Chemotherapie einschließlich Dacarbazin für Hodgkin-Lymphome entscheidend; eine unzureichende Behandlung kann das Risiko für ein Rezidiv deutlich erhöhen. Daher sollte ABVD als Therapie der ersten Wahl gelten, auch wenn die Evidenz für eine Chemotherapieempfehlung bei schwangeren Patientinnen dürftig ist [4]. Das Ansprechen und die Überlebens-raten sind mit denen nichtschwangerer Patientinnen vergleichbar [1].…”
Section: Introductionunclassified